Hydroxylation of demethoxy-Q6 constitutes a control point in yeast coenzyme Q6 biosynthesis by Padilla, Sergio et al.
Hydroxylation of demethoxy-Q6 constitutes a control point in
yeast coenzyme Q6 biosynthesis
S. Padillaa, U. C. Tranb, M. Jiménez-Hidalgoa, J. M. López-Martína, A. Martín-Montalvoa, C.
F. Clarkeb, P. Navasa, and C. Santos-Ocañaa
C. Santos-Ocaña: csanoca@upo.es
a Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide-CSIC and Centre for
Biomedical Research on Rare Diseases (CIBERER), Carretera de Utrera, km 1, ISCIII, 41013
Sevilla (Spain), Fax: +34 954 349376
b Department of Chemistry and Biochemistry. UCLA, Los Angeles 90095, CA (USA)
Abstract
Coenzyme Q is a lipid molecule required for respiration and antioxidant protection. Q biosynthesis
in Saccharomyces cerevisiae requires nine proteins (Coq1p–Coq9p). We demonstrate in this study
that Q levels are modulated during growth by its conversion from demethoxy-Q (DMQ), a late
intermediate. Similar conversion was produced when cells were subjected to oxidative stress
conditions. Changes in Q6/DMQ6 ratio were accompanied by changes in COQ7 gene mRNA
levels encoding the protein responsible for the DMQ hydroxylation, the penultimate step in Q
biosynthesis pathway. Yeast coq null mutant failed to accumulate any Q late biosynthetic
intermediate. However, in coq7 mutants the addition of exogenous Q produces the DMQ
synthesis. Similar effect was produced by over-expressing ABC1/COQ8. These results support the
existence of a biosynthetic complex that allows the DMQ6 accumulation and suggest that Coq7p is
a control point for the Q biosynthesis regulation in yeast.
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Introduction
Coenzyme Q (ubiquinone, Q) is an isoprenylated benzoquinone involved in respiration [1],
and in the defense against oxidative stress [2]. The location of Q biosynthesis may depends
on the organism analyzed. It is synthesized in mitochondria and then distributed among the
other membranes of the cell through the endomembrane system pathway in human cells [3].
Saccharomyces cerevisiae shares with human cells the same location based on the presence
of mitochondrial import signals and also its mitochondrial localization by
immunolocalization analysis [4]. However, other locations have been reported for
mammalian cells [5,6] and in pathogenic fungus such as Pneumocystis sp. [7,8]. The number
of isoprenoid units (n) in the polyprenyl tails of Qn varies depending on the species; humans
produce Q10, Saccharomyces cerevisiae produce Q6, and Caenorhabditis elegans produce
Q9. Addition of exogenous Q with different tail lengths can augment respiration, but may
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also induce oxidative stress in mitochondria [3] and impact longevity [9–11], indicating that
Q may affect a variety of cellular pathways [12].
At least nine genes are involved in Q biosynthesis in the yeast S. cerevisiae (COQ1–COQ9)
[13,14]. As is shown in Figure 1, the protein products of some of these genes have known
catalytic functions in eukaryotic Q biosynthesis, but the function of Coq4, Coq6, Abc1/
Coq8, and Coq9 still require characterization [13,15–17].
In yeast coq null mutants (coq3-coq9), 3-hexaprenyl-4-hydroxybenzoic acid (HHB) is the
only Q biosynthetic intermediate detected [13,15,18,19]. It is possible that this result can be
explained because most of the other Q-intermediates are rapidly degraded, but a growing
body of evidence suggests interactions among Coq proteins lead to formation of a Q-
biosynthetic complex [20–22,23]. However, little is known about the regulation of this
pathway in eukaryotic cells. A decrease of the antioxidant α-tocopherol induces Q
biosynthesis in rat liver [24], and calorie restriction maintains the Q10/Q9 ratio in long-lived
rats compared to those fed ad libitum [25]. Nevertheless, molecular mechanisms involved in
this regulation are still unknown [17].
Yeast coq7 null mutants accumulate HHB, but yeast strains harboring coq7 point mutations
that lead to amino acid substitutions G104D or E194K also produce 2-hexaprenyl-3-methyl-6-
methoxy-1,4-benzoquinone (demethoxy-Q6, or DMQ6) [26,27]. This intermediate is also
accumulated in C. elegans clk-1 mutants [28] and clk-1/coq-7 knockout mice [29]. Both
mutants fail to complete development, although dietary Q partially rescues C. elegans clk-1
mutants [30,31]. DMQ6 fails to support both respiration and antioxidant functions in S.
cerevisiae, but because a small amount of this intermediate is accumulated in wild-type
yeast, it may have a specific function in the Q biosynthetic pathway [32].
Here we show that DMQ6 is accumulated during early log phase of growth of S. cerevisiae.
We investigate mechanisms responsible for changes in the cellular content of Q6 and DMQ6
during growth and in response to oxidative stress. The findings presented here support a
model describing two phases of Q biosynthesis. The first phase requires the interactions of
several of the Coq polypeptides, and Q6 itself, to produce DMQ6. The second phase is
defined by the conversion of DMQ6 to Q6, and this conversion is regulated by growth phase
and by linolenic acid-induced oxidative stress.
Materials and Methods
Yeast strains and growth media
Yeast strains used in this study are shown in Table 1. Growth media for yeast was prepared
as described [33] and included YPD (1% yeast extract, 2% peptone, 2% dextrose), YPD10
(YPD containing 10% glucose instead of 2%), YPG (1% yeast extract, 2% peptone, 3%
glycerol), SDC (0.18% yeast nitrogen base without amino acids, 2% dextrose, 0.14%
NaH2PO4, 0.5% (NH4)2SO4, and complete amino acid supplement), and SD-Ura (SDC, but
amino acid supplement lacks uracil). Yeasts were grown at 30 °C with shaking (200 rpm).
Plasmid pMCOQ4 was created by digesting the plasmid pTL4 [15] with BamHI and ligating
the fragment to pRS426 that had been similarly treated. Plasmid pMABC1 was created by
digesting the plasmid p3HN4 [16] with SalI and NotI and ligating the fragment with pRS426
that had been similarly treated. pMCOQ4 and pMABC1 plasmids were used to transform
the CEN.MP3–1A yeast strain using the lithium acetate-PEG method [34].
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Oxidative stress treatment
Yeast cells were cultured in YPD10 overnight (OD600nm = 9–10), washed and resuspended
in sterile 100 mM sodium phosphate buffer, pH 6.2, with 0.2% glucose, at 180 × 106 cells/
ml. Cell suspensions were incubated with 1 mM H2O2, 750 μM oleic acid, or 750 μM
linolenic acid for four hours.
In vivo labeling of Q6 and Q6-intermediates
p-[U-14C]-hydroxybenzoic acid ([14C]-pHB) was synthesized from L-[U-14C]-tyrosine as
previously described [3]. Yeast strains were grown in YPD at 30 °C with shaking (200 rpm)
for 48 h in the presence of [14C]-pHB (17 nM or 105 14C-dpm/ml of medium).
Identification of Q6 and Q6-intermediates by HPLC/ECD
Lipid extractions of whole cells and quantification of Q6 and Q6-intermediates were
performed as described [35]. Coenzyme Q9 was used as an internal standard; 1 μg Q9 was
added per g wet weight cell pellet. Lipid components were separated with a Beckmann 166–
126 HPLC system equipped with a 15 cm Kromasil C-18 column in a column oven set to 40
°C, with a flow rate of 1 ml/min and a mobile phase containing 88/24/10 methanol/ethanol/
2-propanol and 13.4 mM lithium perchlorate. Quinones were quantified with an ESA
Coulochem III electrochemical detector (ECD) and a 5010 analytical cell (E1, −500mV; E2,
+500mV). Hydroquinones present in samples were oxidized with a pre-column cell set in
oxidizing mode (E +500mV). Q6 and Q9 were quantified with external standards.
RPHPLC-APCI-MS/MS multiple reaction monitoring analysis
One gram wet weight pellets of yeast strains as indicated were harvested at 44 hours (14–26
OD/ml) harvested from YPgal media: (2% galactose, 0.1% dextrose) and collected by
centrifugation at 1000 × g in 50 ml tared borosilicate glass conical tubes with Teflon-lined
caps. These were stored at −20 °C until extraction. Samples were thawed on ice, and 183
pmol of internal standard was added (Q4, Sigma) to samples and standards. This was
followed by 1 ml water and 16 ml hexane/2-propanol (3/2, v/v) [36]. After shaking at 200
rpm for 10 minutes the samples were vortexed vigorously for ten seconds and the phases
were allowed to separate while standing at room temperature. The upper phase was removed
to a 50 ml amber glass vial. The lower phase was re-extracted with hexane:2-propanol; 7:2
(8 ml) twice and the pooled organic phases were concentrated by vacuum centrifugation and
stored dry at −20 °C. The four point standard curve (7.8 fmol/μl to 1.01 pmol/μl) was
extracted simultaneously with the cell pellet samples.
Dried samples and standards organic extracts were resuspended in 400 μl neat ethanol.
These crude lipids were separated (50 μl/injection) by a reverse phase column Thermo
Hypersil (Keystone Scientific Operations) BetaBasic 18, 4.6 × 250 mm, 5 μ particle size)
equilibrated in water/acetonitrile (50/50 (v/v); solvent A) and eluted (1 ml/min μl/m) with an
increasing concentration of 100% acetonitrile; solvent B (min/% acetonitrile: 0/90; 3/90;
7/100; 30/100). The eluate was passed directly into an atmospheric pressure chemical
ionization source (APCI, nebulizing gas, “zero”-grade air produced by a Zero Air Generator
(Peak Scientific, Chicago, Il) at 2–3 L/s, nebulizer 450 °C, orifice 50 volts) attached to a
Perkin-Elmer Sciex (Thornhill, Canada) API III triple quadrupole mass spectrometer
operated in the tandem mass spectrometric (MS/MS) mode (99.999% argon collision gas at
an instrumental GCT setting of 200). The mass spectrometer had been previously tuned and
calibrated by flow injection (100 μl/min) of a mixture of polypropylene glycol (PPG) 425,
1000 and 2000 (3.3 × 10−5, 1 × 10−4 and 2 × 10−4 M, respectively) in water/methanol (1/1,
v/v) containing 2 mM ammonium formate and 0.1% acetonitrile. Calibration across the mass
range was made using the singly charged PPG/NH4+ ions at m/z 58.99, 326.25, 906.67,
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1254.92, 1545.13 and 1863.34 with instrument resolution set so the 13C isotope satellites
were resolved with 10–40% valley.
Quantitative data was collected in the multiple reaction monitoring (MRM) mode by
recording the MH+ → tropylium ion transitions (Q6, m/z 591.4 → 197.0; Q4, m/z 455.2 →
197.0 and DMQ6, m/z 561.4 → 167.0) with dwell set to 1000 ms, a pause time of 0.3 ms
and a total scan time of 4.0 seconds. Standards (DMQ3 and Q3) were fragmented and used to
confirm the identity of the ions. Synthesis of DMQ3 was as described [22].
MRM peak areas were measured by instrument manufacturer supplied software (MacSpec™,
version 3.3, PE Sciex, Ontario, Canada). The calibration curve from the extracted set of
standards (ordinate, Q6/Q4 peak area ratio; abscissa, Q6 amount) had correlation coefficient
(r2) of 0.99 with slope = 4.68 (intercept forced to zero). Concentrations of Q6 and DMQ6 (in
Q6 equivalents) present in the extracts were directly interpolated from the calibration curve,
and quantities in each fraction were calculated after correction for dilution and amount
assayed. Lipid extractions and analyses were completed on independent replicate yeast
pellets and were injected twice. The data presented represent independent replicate cell
pellets and duplicate LC/MS-MS analyses.
RNA isolation and cDNA synthesis
Cells (200 × 106) were harvested by centrifugation and washed twice in DEPC-treated
water. Cells were resuspended in 200 μl 20 mM Tris-HCl, pH 7.4, with 30% glycerol, frozen
in N2(l) and stored at −80 °C until use. For total RNA isolation, cells were thawed and
washed with DEPC-treated water. Each cell pellet was resuspended in 500 μl cell-wall-
digestion buffer (50 mM potassium phosphate, pH 7.4, 10 mM DTT) and incubated 45 min
at 30 °C in the presence of 10 μl Zymolyase 20T, 10 mg/ml (Seikagaku Corporation, Japan).
Spheroplasts were collected by centrifugation and total RNA was isolated (Eppendorf
Perfect RNA Eukaryotic Mini kit) and quantified with a Nanodrop ND-1000
spectrophotometer (NanoDrop Technologies, Wilmington, DL USA). cDNA was
synthesized from 1 μg of total RNA in a 20 μl reaction containing Moloney Murine
Leukemia Virus (M-MuLV) reverse transcriptase buffer, 40 U M-MuLV, 1 mM dNTP mix,
20 U RNase inhibitor (Fermentas Life Sciences, Vilnius, Lithuania) and 500 ng oligo(dT)
from MWG, Ebersberg, Germany. Each reaction was performed for 1 h at 42 °C according
to manufacturer’s directions.
Primers and DNA competitors
Primers were designed with Primer Premier 5.00 software (Premier Biosoft International,
Palo Alto, CA, USA) and the available sequence information from SGD yeast database
(Table 2). For each gene analyzed, a competitor fragment was generated with recombinant
PCR. The competitor fragment was amplified from genomic DNA [33] with the competitor
primers (i.e. ABC1-ComF and ABC1-ComR). These primers contain the 5′ and 3′ specific
ends of the sequence used as competitor and a tail corresponding to the sequence of primers
used to amplify the target gene (i.e. ABC1-U210 and ABC1-L1260). The competitor was
cloned in a T-hang vector such as pMBL (Dominion-MBL SL, Córdoba, Spain) and
sequenced to confirm the construct (MWG, Ebersberg, Germany). The target gene fragment
was also cloned in the same vector. For analyses of the COQ genes, the ACT1 gene was used
as a competitor. For analyses of the ACT1 gene (used as calibrator) the COQ5 gene was used
as competitor. The competitor required for expression analyses was amplified by PCR with
the appropriate target primers, extracted from agarose (Eppendorf Perfect Gel Cleanup), and
quantified by absorbance spectrophotometry. The designated competitor DNA products
were prepared and purified freshly for each set of experiments.
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Amplification kinetics and determination of the optimal concentration of the competitor
DNAs
To test the quality of competitor, each target-competitor pair (0.1 attomol) were used as
template for the PCR in the presence of target primers. Samples were removed at the
specified cycle number (from cycles numbered 23 to 30), and resolved by agarose gel
electrophoresis (Fig. 2A). Both competitor and target specific DNA fragments were
quantified with a gel analyzer (Gel Doc 1000, Bio-Rad Laboratories, Hercules, CA, USA).
Data obtained were subjected to linear regression analysis validating the effectiveness of
each competitor (Fig. 2B). In order to determine the optimal amount of competitor 10-fold
serial dilutions of competitor (100–0.1 attomol) were amplified together with constant
aliquots (2 μl) of cDNA from the wild-type strain CEN.PK2-1C with target primers and
PCR samples were resolved by agarose gel electrophoresis (Fig. 2C). Band intensities were
quantified and expressed as arbitrary units (AU). After a correction depending of the
fragment size, the base-10 logarithm of the target/competitor ratio was calculated. The ratios
were plotted against the logarithm of the amount of competitor added (Fig. 2D). This plot
was used to calculate the equivalence point, the point in which the logarithm of the ratio
target/competitor is equal to 0 (target concentration equal to competitor concentration). The
measured concentration of the competitor determined the concentration to be used in the
expression analysis experiments.
Competitive RT-PCR expression analyses
Samples of yeast cDNA (2 μl from a 20 μl reaction containing 1 μg of total yeast RNA)
were amplified together with constant amounts of competitor in a volume of 25 μl. PCR
reaction mixtures were resolved by agarose gel electrophoresis and the band intensities were
used to calculate the logarithm of the ratio target/competitor. Differences in these ratios
indicate differences in expression. Competitive RT-PCR expression method was performed
as was described with minor modifications [37,38].
Results
DMQ6 is a predominant Q6-intermediate in log phase yeast cultures
To study the regulation of Q6 biosynthesis in yeast, we first analyzed the concentrations of
both DMQ6 and Q6 throughout the growth in both non-fermentable (YPG) (Fig. 3A) and
fermentable (YPD) media (Fig. 3B). The Q6/DMQ6 ratio was significantly decreased (from
4.0 to 0.5) during the first 10 h culture in YPG culture, due to the transient accumulation of
DMQ6 (Fig. 3A and 3C). The amount of DMQ6 was surprisingly persistent; even after 24
and 48 hours of culture the content of DMQ6 remained high. Yeast grown in YPD showed
also a transient increase in DMQ6 content; the Q6/DMQ6 ratio decreased from 4.4 to 2.0
over the first 10 h. This trend was then reversed by the increase in Q6 content yielding a
ratio of 5.0 by 24 h (Fig. 3B).
Changes in COQ RNA levels as a function of growth phase and culture
Results showed above suggest the existence of a biochemical mechanism through yeast cells
could regulate Q6 biosynthesis by modulation of DMQ6 to Q6 transformation rate. To
further investigate this process mRNA levels of several genes involved in Q6 biosynthesis
pathway (COQ genes) were determined. Seven of the nine COQ genes products in yeast
(Coq3-Coq9) are required for ring modification of Q6 molecule [20,21,23] and Coq7p is the
enzyme involved in DMQ6 hydroxylation (Fig. 1). Therefore, mRNA levels of COQ3,
COQ4, COQ5, COQ7 and ABC1 genes were measured in yeast grown in YPG and YPD
media (Fig. 3A and 3B). In general COQ RNA levels are higher in yeast grown in YPG
(Fig. 4A). COQ7, ABC1/COQ8, COQ5, and COQ3 RNA levels tend to increase (from 2- to
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7-fold) with time in culture. Changes in COQ RNA levels as a function of growth phase in
YPD media are fairly modest (Fig. 4B), however, COQ7 RNA levels were significantly
elevated as cells transit from log to stationary phase. These results suggest that there are at
least two phases in Q6 biosynthesis; one leading to DMQ6 biosynthesis driven by a slow
increase of the expression of COQ genes, and a second phase, driven by the expression of
COQ7, where the final ring hydroxylation and methylation steps produce Q6.
The conversion of DMQ6 to Q6 responds to oxidative stress
Previous studies have demonstrated antioxidant properties of coenzyme Q. Yeast strains that
are unable to synthesize Q6 or producing only DMQ6 are very sensitive to oxidative stress
induced by H2O2 and linolenic acid [32,39]. Therefore, yeast cells under oxidative stress
conditions could potentially activate Q6 synthesis in order to increase protection from
oxidative damage. To test this hypothesis, in yeast subjected to oxidative stress we have
analyzed the content of Q6 and DMQ6 in the wild-type CEN.PK2–1C yeast strain treated
with H2O2, oleic acid, or linolenic acid. This wild-type strain was highly resistant to
treatment with either 1 mM H2O2 or 750 μM linolenic acid [32].
Figure 5A shows that the Q6/DMQ6 ratio was increased (from 0.3 to 0.8) in yeast treated
with linolenic acid for 4 h. That increase was due mainly to a shift of DMQ6 intermediate to
Q6, because total amount of quinones remained unchanged. H2O2 did not affect the Q6/
DMQ6 ratio and even produced a decrease in total quinone content. It is likely that the
protective response elicited by H2O2 treatment is distinct from that elicited by linolenic acid.
Oleic acid was also tested because its provision as a carbon source has been demonstrated to
increase the expression of COQ5. The promoter of the COQ5 gene contains an oleic acid
response element (ORE) that may boost Q6 synthesis [40]. However, when provided at the
same concentration as linolenic acid, oleic acid treatment does not produce significant
changes in the Q6 and DMQ6 levels.
To investigate whether the oxidative stress treatments affected COQ gene expression, we
analyzed the steady state COQ RNA levels. Linolenic acid, but neither H2O2 nor oleic acid,
increased both COQ7 and COQ3 RNA levels following a 4 h treatment relative to control
(Fig. 5B). Other COQ RNA levels examined did not change significantly, including COQ5,
in response to oleic acid treatment (Fig. 5B). These results suggest that treatment with
linolenic acid acts to increase COQ7 and COQ3 RNA levels, and acts to enhance the
conversion of DMQ6 to Q6 as a mechanism to provide antioxidant protection.
DMQ6 can be synthesized in yeast in the absence of Coq7p
Yeast strains harboring null mutations in one of the COQ genes (COQ3 to COQ9)
accumulate HHB (3-hexaprenyl-4-hydroxybenzoic acid), an early Q-intermediate that is the
product of the reaction carried out by Coq2p [13,26,41,42]. Several lines of physical
evidence now indicate the existence of a biosynthetic Coq-polypeptide complex inside
mitochondria [22]. Supplementation of growth media with exogenous Q6 has been shown to
rescue mitochondrial respiration in the yeast coq mutants [43] and to preserve steady state
levels of Coq3 and Coq4 polypeptides [27] of a coq7 null mutant. In addition, it has been
shown that Q6 and DMQ6 are associated with a polypeptide complex defined by Coq3p and
Coq4p products [22]. This latter observation suggests that interaction between Q6 and COQ
genes products could be important for the biosynthetic complex stabilization and regulation
of Q6 biosynthesis. To determine whether the functional interaction among Coq
polypeptides depends on the presence of Q6, we analyzed the effect of addition of
exogenous Q6 on coq null mutants growing in YPD. The analysis of lipid extracts from each
of the coq mutants (coq3-abc1/coq8) indicated that a product co-eluting with DMQ6 was
produced only in the coq7 mutant strain cultured in the presence of exogenous Q6 (Fig. S3).
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To identify the material co-eluting with DMQ6, we performed RP-HPLC/MS-MS analysis
of the lipid extracts prepared from the wild-type parental strain and the coq7 null mutant
cultured in the presence and absence of exogenously added Q6. As described in
experimental procedures, quantitative data was collected in the multiple reaction monitoring
(MRM) mode. This method separates lipid extracts, producing specific retention times for
the compounds of interest; the detection of the lipids involves selection of a specific
precursor (parent) molecule, which is fragmented for quantification of a specific product
(daughter) molecule. By these criteria the Q6 and DMQ6 content in the CEN.PK2–1C wild-
type yeast were 62.73 ± 15.13 and 4.22 ± 1.04 pmol/gm wet weight, respectively. Neither
Q6 nor DMQ6 were present at measurable amounts in the coq7 null yeast strain. However,
when cultured in the presence of exogenous Q6, the coq7 null mutant contained quantities of
both Q6 (8.05 ± 3.16 pmol/gm wet weight) as well as DMQ6 (0.24 ± 0.10 pmol/gm wet
weight). To determine whether the DMQ6 produced by the coq7 mutant represented de novo
synthesis, several of the coq null mutant strains were grown in the presence of [14C]-pHB,
the aromatic ring precursor, and in the presence or absence of exogenously added Q6.
Supplementation of the growth media with exogenously added Q6 did not affect the
incorporation of [14C]-pHB into either DMQ6 or Q6 in the wild-type strain (Fig. S4). Similar
incubations of the coq3 and abc1 null mutant strains showed that neither produced
detectable DMQ6 or Q6, and each produced only a more polar radiolabeled peak eluting at
about 6 min, as predicted for HHB (Fig. 6A and C). However, a significant radiolabeled
peak corresponding to [14C]-DMQ6 was observed in lipid extracts prepared from the coq7
null mutant strain following incubation with [14C]-pHB plus exogenous Q6 (Fig. 6B).
Because growth of the coq7 null mutant in the presence of exogenous Q6 leads to uptake of
Q6 [44], these results indicate that Q6 itself supports interaction of the Coq proteins and
enables de novo synthesis of DMQ6. Thus, Q6 is a crucial lipid component of the Coq
polypeptide biosynthetic complex, and its presence may be required to facilitate formation
of, and/or stabilize, the Coq polypeptide biosynthetic complex. COQ RNA levels were
quantified in the CEN MP3.1A (coq7 null) strain in response to culture in the presence or
absence of exogenous Q6 (Fig. 7). Addition of exogenous Q6 did not produce a change in
COQ3, COQ4, COQ5, or ABC1/COQ8 RNA levels, indicating that the de novo synthesis of
DMQ6 is not driven by changes in RNA levels. Recent studies show that exogenously added
Q6 to coq7 null mutant cultures enhanced the steady state levels of the Coq3 and Coq4
polypeptides [27]. Hence, it is likely that the addition of Q6 acts to stabilize the Coq
polypeptides.
Abc1p and Coq4p regulate DMQ6 synthesis
To further understand whether there are more factors involved in the stabilization of Coq
polypeptides, we analyzed whether an alteration of the expression of certain Coq proteins
would lead to complex stabilization and DMQ6 synthesis in a coq7 null mutant strain. Of the
COQ genes participating in the synthesis of DMQ6, Coq4p and Abc1/Coq8p do not have an
assigned function, although Abc1/Coq8p has recognized sequence motifs that identify it as a
potential Hank’s Ser/Thr protein kinase [17,45]. To study the possible functions of Coq4p
and Abc1/Coq8 in DMQ6 biosynthesis, the yeast coq7 null mutant strain was transformed
with a multicopy plasmid harboring either COQ4 or ABC1 coding sequence including the
natural promoter. The over-expression of COQ4 or ABC1 in the coq7 null mutant does not
produce significant changes in the expression of other COQ genes (Fig. 8A). Lipid extracts
of these cells were analyzed for content of Q6 and DMQ6 by HPLC-ECD. Multicopy
expression of COQ4 produces the synthesis of a small amount of DMQ6 as compared with
the coq7 null mutant strain; however, the multicopy expression of ABC1/COQ8 increases
dramatically the amount of DMQ6, to levels much higher than detected in wild-type cells
(Fig. 8B). These results support a regulatory function for Abc1/Coq8p; and indicate that
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over-expression of Abc1/Coq8p can facilitate the formation of a Coq7p-independent
complex for DMQ6 biosynthesis in S. cerevisiae.
Discussion
Several lines of evidence presented here suggest that hydroxylation of DMQ6 may serve as a
control point in the biosynthesis of Q6. DMQ6 is a predominant intermediate in log phase
yeast cells. As cells transition from log to stationary phase growth, the DMQ6 content
decreases and the Q6 content increases. This regulatory point of coenzyme Q biosynthesis is
not the only in yeast, another regulatory point may be related for the protein Coq2p.
Previous studies [46] have shown that, in yeast cultured with increased concentrations of
glucose, a decrease of Q6 and DMQ6 levels resulted, while HHB increased. This supports
the idea of an initial and strong regulatory point based in a phosphorylation cycle, linked to
the fermentative growth phase in yeast. To investigate whether the control of the content of
DMQ6 and Q6 is due to changes in gene expression, COQ RNA levels were quantified.
COQ RNA levels were generally higher in cells grown in media containing glycerol (YPG)
as compared to dextrose (YPD). This has been observed previously [15,47,48]. In YPG
media COQ7, ABC1/COQ8, COQ5 and COQ3 RNA levels increased (from 2- to 7-fold) as
cells transitioned from log to stationary phase. In contrast, COQ RNA levels in YPD media
stay fairly constant, except for COQ7 RNA levels, which increase about 5-fold in stationary
phase cells as compared to log phase. The data suggest that Q6 synthesis may take place in
two phases; the first phase produces DMQ6 as a predominant intermediate, and the second
phase is driven by the induced expression of the COQ7 gene, which is a member of the di-
iron carboxylate family of proteins and catalyzes the hydroxylation of DMQ6 [49], enabling
the final O-methylation step to produce Q6.
We show that treatment with linolenic acid, but not oleic acid, increased Q6 content,
decreased DMQ6, and increased COQ7 and COQ3 RNA levels (Fig. 5). Linolenic acid, a
polyunsaturated fatty acid, is prone to autoxidation, and products of linolenic acid
autoxidation are toxic to Q-deficient yeast, which can be rescued by restoration of Q6
biosynthesis, or by the addition of exogenous Q6 [32,39]. These studies indicate that reduced
Q (QH2) serves as an essential lipid soluble antioxidant [50]. Because the hypersensitivity is
observed in response to linolenic acid, but not oleic acid, (a monounsaturated fatty acid that
is much more resistant to autoxidation), we propose that the increase in COQ7 and COQ3
RNA levels represents a stress response. Transcription of the yeast COQ5 gene is induced
by growth in media containing oleic acid as sole carbon source [51]. However, in our studies
treatment with oleic and linolenic acid were performed at lower concentrations of fatty acid
and for only a short time (four hours). Our interpretation is that the linolenic acid-induced
oxidative stress acts to degrade Q6, and the increase in DMQ6 content and in COQ3 and
COQ7 RNA levels represents a cellular stress-response to replenish Q6 and provide
antioxidant protection. Up-regulation of Q biosynthesis in response to vitamin E deficiency
in rats has been previously demonstrated [24]. Notably, COQ7 gene expression was induced
in small lung cancer cells following treatment with camptothecin [52]. The induction of
COQ7, and resulting increase in cellular Q content was postulated to protect these cells from
the stress caused by this topoisomerase I inhibitor.
The yeast coq7 null mutant accumulates HHB (hydroxyl hexaprenyl benzoate) [26].
However, we show here that accumulation of newly synthesized DMQ6 was induced in
yeast coq7 null mutants by either addition of exogenous Q6 or over-expression of the ABC1/
COQ8 gene. The identity of DMQ6 was verified by RP-HPLC/MS-MS analyses and
identification of the parent ion and its fragmentation to a specific daughter ion. Furthermore,
the production of DMQ6 represents de novo synthesis because incubation of the coq7 null
mutant in the presence of [14C]-4-HB, the aromatic ring precursor of Q biosynthesis, led to
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the production14C-DMQ6, but only if the growth media was supplemented with exogenous
Q6. This was a unique feature of the coq7 null mutant, as DMQ6 was not detected when any
of the other coq null mutants were cultured in the presence of exogenous Q6. Previous
studies have shown that coq null mutants take up exogenously supplied Q6, with a
restoration of respiratory electron transport. Supplemental Q6 also acts to enhance steady
state levels of the Coq3 and Coq4 polypeptides in the coq7 null mutant [27], but does not
affect COQ RNA levels (Fig. 7). The results presented here indicate that Q6 itself serves as a
crucial lipid component and acts to facilitate formation of, and/or stabilize the Coq
polypeptide Q6-biosynthetic complex. Our results also show that the Abc1/Coq8 polypeptide
may serve a similar function, as its overexpression in the coq7 null mutant also allowed
DMQ6 to be produced.
Aside from its function as a Q biosynthetic intermediate, what is the role of DMQ6?
Although postulated to function in respiratory electron transport or as an antioxidant [53],
this seems unlikely because yeast mutants that lack Q6 and produce only DMQ6 are
respiratory defective and hypersensitive to oxidative stress [32,44]. Several lines of evidence
support the idea that DMQ6 functions as a lipid component of the Coq polypeptide
biosynthetic complex. Genetic evidence argues for the involvement of Q or a Q-intermediate
in stabilizing the Coq3, Coq4, and Coq6 polypeptides [21]. DMQ6 co-elutes with Coq3,
Coq4 and Coq6 polypeptides as a high molecular weight complex when digitonin extracts of
mitochondria are subjected to size exclusion chromatography [22]. Certain yeast coq7 point
mutants (e.g. coq7E194K) have higher steady state levels of the Coq3 and Coq4
polypeptides and produce DMQ6. Although the enhanced Coq3 and Coq4 polypeptide levels
may be due to the presence of the Coq7-E194K polypeptide, it is also possible some of the
effects are due to the presence of the DMQ6 intermediate itself [27]. Finally, we note that as
an unsubstituted quinone, DMQ6 is a potentially potent electrophile that may participate in
Michael addition reactions and modify a variety of nucleophilic groups [54]. In fact, H2O2
incubation does not affect the expression of COQ genes (Fig. 5B) but increases the Q6/
DMQ6 ratio (Fig. 5A) decreasing the DMQ6 level. However, linolenic acid increases the
expression of COQ7 and COQ3 genes together with an increased Q6/DMQ6 ratio. This data
point to a possible DMQ6 degradation but only produced by H2O2. This differential
behavior of both oxidative stress agents supports the idea that DMQ6 may be protected by its
accumulation in Q6 biosynthetic complexes or in mitochondrial respiratory complexes
containing endogenous Q6 such the bc1 complex. Thus, previous studies [32] have shown
that in yeasts that only produce DMQ6, the incubation with linolenic acid increases the
superoxide anion generation. This effect was not seen in wild type strains that produce both
Q6 and DMQ6. The protective effect can be deduced by the fact that DMQ6-producing
strains cannot stabilize the bc1 complex [32,44]
These results support a model where DMQ6 biosynthesis in S. cerevisiae may take place in
the complete absence of the Coq7 polypeptide, provided either the lipid product Q6 is
present, or Abc1/Coq8 is overexpressed. The role of Abc1/Coq8 polypeptide in Q
biosynthesis is not known, but based on sequence motifs it has been identified as Hank’s
protein kinase [45]. Thus, Abc1/Coq8p is a candidate for the post-translational regulation of
Q biosynthesis. Overexpression of ABC1/COQ8 suppresses the effect of coq9–1 mutation in
S. cerevisiae [13]. Here we show ABC1/COQ8 overexpression allows coq7 null mutants to
produce DMQ6.
These results support the hypothesis that Coq7p regulates the rate of Q biosynthesis in yeast.
A complex of Coq polypeptides serves to generate DMQ6, a prevalent Q-intermediate in log
phase cells. The second phase of Q biosynthesis entails the hydroxylation of DMQ6 by
Coq7p, and subsequent O-methylation by Coq3p to form Q6. This idea was strongly
supported by classical studies on coenzyme Q biosynthesis in rat liver, where DMQ9 was
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accumulated during Q9 biosynthesis analysis performed in liver slices [55]. Therefore, the
final Q6 synthesis requires the interaction of the Coq7 polypeptide with the first organized
complex. The transitions between these two complexes may serve as a control point for Q6
biosynthesis, and the accumulation of DMQ6 itself may provide a reserve for the rapid
supply of Q6.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Scheme of coenzyme Q6 biosynthesis. HHB (3-hexaprenyl-4-hydroxybenzoic acid) is
produced by the action of COQ1 and COQ2 proteins. HHB is converted to 3,4-dihydroxy-5-
hexaprenylbenzoic acid (DHHB) by an unidentified enzyme. The O-methyltransferase
encoded by COQ3 catalyzes the next step to produce 3-methoxy-4-hydroxy-5-
hexaprenylbenzoic acid. Several modifications of the head group results in 5-
demethoxyubiquinone (DMQ6). Coq7p, a monooxygenase, converts DMQ6 to 5-
demethylubiquinone, which is methylated again by the Coq3p O-methyltransferase to
produce Q6.
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Figure 2.
Design of a competitor for the ABC1/COQ8 gene. The complete procedure is described in
Experimental Procedures. In this example, a 768 bp fragment of the ACT1 gene was
amplified from genomic DNA with the primers ABC1-ComF/ABC1-ComR to produce an
810 bp fragment corresponding to the ACT1 gene plus a flanking region recognized by the
primers ABC1-U210/ABC-L1260. This fragment is the ABC1 competitor. The primers
ABC1-U210/ABC-L1260 amplify a 1050 bp fragment from yeast genomic DNA
corresponding to the ABC1/COQ8 gene. Both fragments (1050 and 810 bp) were purified
and 0.1 attomol of each were used separately as template for PCR with the ABC1-U210/
ABC-L1260 primers. PCR samples were removed at the specified cycle number (23 to 30
cycles) and resolved by electrophoresis on a 1% agarose TBE gel (A). The band intensities
were measured and plotted against the number of cycles to determine the efficiency of each
reaction (B; closed and open circles represent the competitor and ABC1, respectively). In
order to determine the optimal amount of competitor DNA, 10-fold serial dilutions of
competitor (100–0.001 attomol) were added to a constant amount of cDNA from the wild-
type strain CEN.PK2–1C (2 μl from a 20 μl RT-PCR reaction made with 1 μg total RNA).
The primers ABC1-U210/ABC-L1260 were added, PCR performed, and the DNA products
resolved by agarose gel electrophoresis (C). The logarithm of the ratio of the ABC1 fragment
and the ABC1 competitor fragment was plotted against the logarithm of ABC1 competitor
(D). The equivalence point corresponds to the competitor concentration that produces a ratio
equal to zero. The amount indicated is the amount of competitor added in subsequent
experiments to quantify ABC1/COQ8 RNA levels.
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Figure 3.
Yeast cell content of Q6 and DMQ6 during growth in YPG and YPD. CEN.PK2–1C cells
(0.1 OD660nm/ml) were grown in YPG (A) and YPD (B) media. At the indicated times
samples of 1 g wet weight cells were subjected to a lipid extraction and separation by
HPLC-ECD to quantify Q6 and DMQ6. Data are expressed as the average of three injections
from two samples obtained in the same culture ± SD. Closed and open circles designate Q6
and DMQ6, respectively. Cell growth was inserted as the dashed line. In panel C are shown
two chromatograms corresponding to YPG culture at 4 and 10 hours.
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Figure 4.
Expression of COQ genes during growth in YPG and YPD media. CEN.PK2–1C cells (0.1
OD660nm/ml) were grown in YPG and YPD culture media. At the indicated times samples of
200 × 106 cells were subjected to total RNA purification. Levels of COQ RNAs were
measured as described in Experimental Procedures and Figure 2. The amount and size of
competitor DNA added to each PCR reaction are as follows: 500 attomol ACT1, 840 bp; 60
attomol COQ3, 352 bp; 9 attomol COQ4, 701 bp; 2 attomol COQ5, 542 bp; 2 attomol
COQ7, 542; and 8 attomol ABC1, 810 bp. Target size were 983 bp ACT1, 588 bp COQ3,
977 bp COQ4, 796 bp COQ5, 708 bp COQ7, and 1050 bp ABC1. PCR samples from YPD
cultures (Fig. S1A) and YPG cultures (Figure S1B) were resolved by electrophoresis on a
1% TBE agarose gel, and densitometry analyses were performed according to Experimental
Procedures. Expression data for YPG (A) and YPD (B). Symbols correspond to COQ3 (●),
COQ4 (○), COQ5 (▼), COQ7 (△) and ABC1 (■). ACT1 RNA levels were used to
normalize each of the COQ RNAs, and corrections were made to account for effects of
fragment size. Data correspond to the average of two independent PCR reaction ± SD using
the same total RNA sample. This experiment is representative of a set of three.
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Figure 5.
COQ RNA levels and content of Q6 and DMQ6 in response to oxidative stress. CEN.PK2–
1C cells were subjected to different oxidative stress conditions (1mM H2O2, or 750 μM
linolenic acid) or to control treatments (no addition, or 750 μM oleic acid) for four hours.
Cells (900 × 106) were collected and analyzed for quinone content as described (A; Q6,
black bars; DMQ6, gray bars). About 200 × 106 cells were collected to determine COQ
RNA content (Fig. S1C), and densitometry data were plotted to calculate gene expression
(B). Bars correspond (from white to black) to COQ3, COQ4, COQ5, COQ7 and ABC1/
COQ8 genes. Control, cells without oxidative stress treatment; H, 1mM H2O2 incubation;
LA, 750 μM linolenic acid; OA, 750 μM oleic acid. RNA levels presented are from the
average of two independent PCR reactions ± SD derived from the same total RNA sample.
Data are representative of two similar experiments.
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Figure 6.
Unique de novo synthesis of DMQ6 in coq7 null yeast mutants cultured in the presence of
exogenously added Q6. (A) Yeast CEN.PK2–1C (wild-type), coq3, coq7, or abc1/coq8 null
mutants were cultured in YPD in the presence of [U-14C]p-hydroxybenzoic acid. Where
indicated, media was also supplemented with 2 μM Q6. Cells were collected and subjected
to lipid extraction and separation by RP-HPLC coupled to a radiometric detector in order to
detect 14C-Q6 and 14C-Q6-intermediates. The profile of 14C-labeled material detected in
lipid extracts of CEN.PK2–1C is shown as the bottom trace in each panel. (A) coq3; (B),
CEN.MP-1A (coq7); and (C) abc1/coq8. Data shown correspond to a representative
experiment of a set of two.
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Figure 7.
Q6 supplementation does not affect COQ RNA content in the coq7 null mutant. The
CEN.MP3–1A strain (coq7) was cultured in YPD in the presence (+Q6) or absence (−Q6) of
exogenous Q6 (2 μM). Total RNA was isolated and the content of COQ RNA was
determined as previously described (Fig. S2A). Densitometry data were plotted to calculate
RNA levels in the absence (black bars) or presence (white bars) of Q6 supplementation.
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Figure 8.
Expression of yeast ABC1/COQ8 in multicopy facilitates production of DMQ6 in the coq7
null mutant. CEN.MP3–1A (coq7) null mutant yeast harbouring the ABC1/COQ8, COQ4, or
empty vector on multicopy plasmids were cultured in SDc–Ura +glucose media for 16
hours. Total RNA was isolated from 200 × 106 cells and the content of COQ RNA was
determined as previously described (Fig. S2B). Band intensities were quantified by
densitometry and plotted to calculate COQ RNA levels (A). Bars correspond to RNA
content of COQ3, COQ4, COQ5, and ABC1/COQ8 (from white to black). The same cells (1
g wet weight) were collected and subjected to lipid extraction and separation by HPLC-ECD
to detect lipid quinones (B). CEN.MP3–1A with the empty vector pRS426 (coq7); with
multicopy ABC1/COQ8 gene (coq7::ABC1); CEN.MP3–1A with multicopy COQ4
(coq7::COQ4); Q6 standard (25 ng).
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Table 1
Genotypes and sources of S. cerevisiae strains.
Strain Genotype Source
CEN.PK2–1C MATa, his3-Δ1, leu2–3,112, trp1–289, ura3–52, MAL2–8c, MAL3, SUC2 [56]
CEN.MP3–1A CEN.PK2–1C, coq7::HIS3 [56]
CEN coq3 CEN.PK2–1C, coq3::LEU2 [23]
CEN abc1 CEN.PK2–1C, abc1::HIS3 [23]
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Table 2
Primers used in this work.
Name Sequence (5→→ 3→)
COQ3-U3 GGGATTCATAATGTTGTT
COQ3-L926 AAATAATTACCGACATCG
COQ3-ComF GGGATTCATAATGTTGTTATTGATAACGGTTCTGGTATGTG
COQ3-ComR AAATAATTACCGACATCGGTACTTTCTTTCTGGAGGAGCA
COQ4-U25 TCAACAGCTACTTTGCCAGTG
COQ4-L1002 TGGAGTCGTGGCTCGTTT
COQ4-ComF TCAACAGCTACTTTGCCAGTGATTGATAACGGTTCTGGTATGTG
COQ4-ComR TGGAGTCGTGGCTCGTTTGTACTTTCTTTCTGGAGGAGCA
COQ5-U61 AGGTGTTTTACGCAAGCTACA
COQ5-L836 TACCTGCCTTCTCAATCATGG
COQ5-ComF AGGTGTTTTACGCAAGCTCACGAAGCTCCAATGAACCCT
COQ5-ComR ATCCTGCCTTCTCAATCATGGCCGGCAGATTCCAAACCC
COQ7-U22 CGAGAGTTTTATTCTTGTGAA
COQ7-L709 ATGCTTGATAGCGGTGTCTAG
COQ7-ComF CGAGCGTTTTATTCTTGTGAAGAAGCTCCAATGAACCCT
COQ7-ComR ATGCTTGATAGCGGTGTCTAGCCGGCAGATTCCAAACCC
ABC1-U210 ACCAACTTCACGAATATCGAG
ABC1-L1260 GGTTCACCAAGTGTAAGTACA
ABC1-ComF ACCAACTTCACGAATATCGAGTTCTGAGGTTGCTGCTTTGG
ABC1-ComR GGTTCACCAAGTGTAAGTACAACTTTCGTCGTATTCTTGTTTTGA
ACT1-U28 ATTGATAACGGTTCTGGTATGTG
ACT1-L1011 GTACTTTCTTTCTGGAGGAGCA
ACT1-ComF ATTGATAACGGTTCTGGTATGTGAGGTGTTTTACGCAAGCTCAC
ACT1-ComR GTACTTTCTTTCAGGAGGAGCAATCCTGCCTTCTCAATCATGG
ACT1-F TTCTGAGGTTGCTGCTTTGG
ACT1-R ACTTTCGTCGTATTCTTGTTTTGAG
Cell Mol Life Sci. Author manuscript; available in PMC 2011 April 4.
